Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedOct 19, 2016ketamine HClStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0054-2017Class IITerminatedOct 19, 2016ketamine HClStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0053-2017Class IITerminatedOct 19, 2016HYDROmorphone HClStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0052-2017Class IITerminatedOct 19, 2016HYDROmorphone HClStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0051-2017Class IITerminatedOct 19, 2016HYDROmorphone HClStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0050-2017Class IITerminatedOct 19, 2016HEPARIN Sodium Inj. USPSubpotent Drug and Stability Data Does Not Support Expiry: confirmed subpotency and potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0049-2017Class IITerminatedOct 19, 2016HEPARIN Sodium InjStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0048-2017Class IITerminatedOct 19, 2016HEPARIN Sodium Inj. USPStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0047-2017Class IITerminatedOct 19, 2016glycopyrrolateStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0046-2017Class IITerminatedOct 19, 2016glycopyrrolateStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0045-2017Class IITerminatedOct 19, 2016glycopyrrolateStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0044-2017Class IITerminatedOct 19, 2016fentaNYL CitrateStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0043-2017Class IITerminatedOct 19, 2016fentaNYL CitrateStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0042-2017Class IITerminatedOct 19, 2016fentaNYL CitrateStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0041-2017Class IITerminatedOct 19, 2016fentaNYL CitrateStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0040-2017Class IITerminatedOct 19, 2016fentaNYL CitrateStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0039-2017Class IITerminatedOct 19, 2016fentaNYL Citrate InjectionStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0038-2017Class IITerminatedOct 19, 2016fentaNYL Citrate InjectionStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0037-2017Class IITerminatedOct 19, 2016fentaNYL CitrateStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0036-2017Class IITerminatedOct 19, 2016fentaNYL CitrateStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0035-2017Class IITerminatedOct 19, 2016fentaNYL Citrate InjectionSubpotent Drug and Stability Data Does Not Support Expiry: confirmed subpotency and potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0034-2017Class IITerminatedOct 19, 2016fentaNYL Citrate InjectionStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0033-2017Class IITerminatedOct 19, 2016Fentanyl Citrate 16.67 mcg per mL and Bupivacaine HCl 0.1667% in 0.9% Sodium ChlorideStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0032-2017Class IITerminatedOct 19, 2016ePHEDrine SulfateStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0031-2017Class IITerminatedOct 19, 2016ePHEDrine SulfateStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0030-2017Class IITerminatedOct 19, 2016ePHEDrine SulfateStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0029-2017Class IITerminatedOct 19, 2016Buffered LidocaineStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0028-2017Class IITerminatedOct 19, 2016Buffered LidocaineStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0027-2017Class IITerminatedOct 19, 2016atropine Sulfate InjectionStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0026-2017Class IITerminatedOct 19, 2016atropine Sulfate InjectionStability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.Pharmedium Services, LLC · D-0025-2017Class IITerminatedOct 19, 2016Amikacin Sulfate InjectionCGMP DeviationsTeva Pharmaceuticals USA · D-0024-2017Class IITerminatedOct 19, 2016Amikacin Sulfate InjectionCGMP DeviationsTeva Pharmaceuticals USA · D-0023-2017Class ITerminatedOct 19, 2016Diocto LiquidMicrobial contamination of Non-Sterile Products; positive findings of Burkholderia cepaciaThe Harvard Drug Group · D-0022-2017Class ITerminatedOct 19, 2016Jenesis Dietary Supplement CapsulesMarketed without an Approved NDA/ANDA; FDA analysis found them to contain sibutramine and phenolphthaleinBee Xtreme · D-0021-2017Class ITerminatedOct 19, 2016Oasis Dietary Supplement CapsulesMarketed without an Approved NDA/ANDA; FDA analysis found them to contain sibutramine and phenolphthaleinBee Xtreme · D-0020-2017Class ITerminatedOct 19, 2016La' Trim Plus Dietary Supplement CapsulesMarketed without an Approved NDA/ANDA; FDA analysis found them to contain sibutramine and phenolphthaleinBee Xtreme · D-0019-2017Class IITerminatedOct 19, 2016Vancomycin 10 mg/mL in 0.9% Sodium ChlorideLack of Assurance of Sterility; all compounded products within expiry produced using recalled filtersLeiter's Compounding · D-0018-2017Class IITerminatedOct 19, 2016Placebo for Prednisolone Acetate 1%Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filtersLeiter's Compounding · D-0017-2017Class IITerminatedOct 19, 2016Moxifloxacin 1 mg/mL in Sterile Balanced Salt SolutionLack of Assurance of Sterility; all compounded products within expiry produced using recalled filtersLeiter's Compounding · D-0016-2017Class IITerminatedOct 19, 2016Mitomycin 0.02%Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filtersLeiter's Compounding · D-0015-2017